News

Sun Pharma subsidiary raises Rs. 1000 crore through debentures

Sun-Pharmaceuticals

Sun Pharmaceutical Industries’ wholly-owned subsidiary Sun Pharma Laboratories Ltd has raised Rupees one thousand crore by allotment of 10,000 unsecured redeemable non-convertible Sun-Pharmaceuticalsdebentures of a face value of Rs.10 lakh each on private placement basis.

These debentures will be listed on BSE under two series with Series 1 debentures comprising of 5,000 debentures amounting to Rs. 500 crore with a tenure of 24 months, and Series 2 debentures comprising of 5,000 debentures amounting to Rs. 500 crore with a tenure of 39 months.

Don't be shellfish...Share on FacebookShare on Google+Share on LinkedInShare on StumbleUponPin on PinterestTweet about this on Twitter
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top